Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00439192
Status:
TERMINATED
Last Update Posted:
2007-08-08
First Post:
2007-02-22
Brief Title:
ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder OAB
Sponsor:
elbion AG
Organization:
elbion AG
Organization Data
Organization:
elbion AG
Class:
INDUSTRY
Study ID:
ELB245201-06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
elbion AG
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None